Biotechnology Jobs

• Waltham, United States
• Hybrid · 2 days in office
• US$222,750 – US$371,250 pa
• Director

Serves as the physician on a clinical program team, leading medical monitoring, safety oversight and data interpretation for oncology and hematology studies. Partners with a Senior Scientist and cross-functional groups on protocol development, regulatory interactions and investigator engagement within a matrix team. May guide other physicians on complex multi-study programs.

AI

• Stevenage
• Hybrid · 2 days in office
• Director

Serves as the physician on a clinical program team, leading medical monitoring and safety oversight for oncology and hematology studies. Interprets clinical and safety data, contributes to protocol development and regulatory interactions, and acts as a core member of the Clinical Matrix Team. May mentor other physicians on complex multi-study programs.

AI

• London
• Hybrid · 2–3 days in office
• Director · manages people

Leads end-to-end clinical development strategy for a hematology oncology portfolio, from first-in-human studies through registrational trials, regulatory approval and initial launch. Provides program oversight at governance forums, co-leads asset development with matrix partners, and line-manages Clinical Development Leads, Medical Directors and Clinical Scientists. Champions novel approaches such as AI/ML, innovative trial designs and real-world data.

AI/ML

• Upper Providence
• Hybrid · 2–3 days in office
• Director · manages people

Leads end-to-end clinical development of hematology oncology assets from first-in-human studies through registrational trials, approval and launch. Sets disease-area strategy, chairs governance forums and advisory boards, and line-manages clinical development leads within a global matrix. Distinct for its portfolio-level enterprise scope and hybrid US/UK/Swiss base.

AI/ML

• Baar Onyx
• Hybrid · 2–3 days in office
• Director · manages people

Leads end-to-end clinical development of hematology oncology assets from first-in-human studies through registrational trials, regulatory approval and initial launch. Chairs governance forums, co-leads matrix asset teams and line-manages clinical development leads, medical directors and clinical scientists. Distinct for its portfolio-level scope across early- and late-phase programs and its cross-functional connector role spanning research, translational medicine and commercial strategy.

AI/ML

• London
• Director

Provides advanced scientific expertise in safety evaluation and risk management for key oncology assets in clinical development, leading signal detection, benefit-risk assessment and regulatory safety submissions. Represents the Safety Evaluation & Risk Management function on cross-functional clinical matrix and project teams, escalating emerging safety issues to senior governance. Mentors junior staff and partners with Safety Physicians to shape long-term safety strategy.

• Poznan Grunwaldzka
• PLN 525,750 – PLN 876,250 pa
• Director

Provides advanced scientific expertise in safety evaluation and risk management for key oncology assets in clinical development, leading signal detection, benefit-risk assessment and regulatory safety submissions. Represents SERM on cross-functional clinical matrix teams, escalates emerging safety issues to governance bodies and mentors junior staff within a global matrix environment.

• Belgium-Wavre
• €141,000 – €235,000 pa
• Director

Provides advanced scientific expertise in safety evaluation and risk management for key oncology assets in clinical development, leading signal detection, benefit-risk assessment and regulatory safety submissions. Represents SERM on cross-functional clinical matrix teams, escalates emerging safety issues to governance bodies and mentors junior staff within a global matrix.

• Siena, Italy
• €124,500 – €207,500 pa
• Director

Provides advanced scientific expertise in safety evaluation and risk management for key oncology assets in clinical development, leading signal detection, benefit-risk assessment and regulatory safety submissions. Represents SERM on cross-functional clinical matrix teams, escalates emerging safety issues to governance bodies and mentors junior staff within a global matrix environment.

• London
• Hybrid · 2–3 days in office
• Mid-level

Delivers performance analysis, market intelligence and targeted market research to help the Europe & International leadership team make commercial decisions. Combines internal performance data, customer engagement analytics and external insights to explain results, identify risks and growth opportunities, and lead priority qualitative and quantitative studies. Works in a matrix with Global Data & Analytics and research teams, with two to three days a week onsite in London.

Global CX Tools

• London
• Hybrid
• Director

Leads the design and delivery of health economics and outcomes research evidence for a portfolio of HIV treatment and prevention medicines, spanning real-world evidence, clinical outcome assessments, evidence synthesis and economic modelling. Shapes integrated value evidence strategies with R&D, medical affairs, market access and external payers/HTA bodies, and sets patient-centred outcomes strategy across the portfolio.

• Philadelphia, United States
• US$203,775 – US$339,625 pa
• Director

Provides scientific and strategic leadership for real-world evidence supporting an mRNA vaccine portfolio, with a primary focus on influenza. Shapes evidence generation across late-stage development, launch and post-marketing, leading US post-marketing vaccine effectiveness studies and external academic and data-partner collaborations. Requires deep expertise in influenza epidemiology, real-world data and causal methods, plus influence across a global matrix.

Medicare · EHR

• Waltham, United States
• US$203,775 – US$339,625 pa
• Director

Provides scientific and strategic leadership for real-world evidence supporting an mRNA vaccine portfolio, with a primary focus on influenza. Shapes evidence generation across late-stage development, launch and post-marketing, leading US post-marketing vaccine effectiveness studies and complex external collaborations with academic and healthcare data partners.

Medicare · EHR · Administrative Claims +1

• London
• US$203,775 – US$339,625 pa
• Director

Provides scientific and strategic leadership for real-world evidence supporting an mRNA vaccine portfolio, with a primary focus on influenza. Shapes evidence generation across late-stage development, launch and post-marketing phases, leading US post-marketing vaccine effectiveness studies and complex external collaborations with academic and healthcare data partners.

Medicare · EHR · Administrative Claims +1

• Durham, United States
• US$203,775 – US$339,625 pa
• Director

Leads the integrated real-world evidence and health outcomes strategy for mRNA influenza vaccines, designing and interpreting US post-marketing vaccine effectiveness studies across late-stage development, launch and post-marketing phases. Partners with clinical development, epidemiology, medical affairs, regulatory, biostatistics and market access teams, and builds collaborations with academic investigators, healthcare systems and data partners. Requires deep expertise in US vaccine effectiveness research, influenza epidemiology, real-world data and causal methods.

Medicare · EHR · Administrative Claims +1